Browsing the "Fidelity Biosciences" Tag →

23 2014 June
By FinSMEs
0 Comments

Dimension Therapeutics Closes $30M Financing

Dimension Therapeutics, a Cambridge, MA-based gene therapy company focused on developing novel treatments for rare diseases, closed a $30m financing....

Read More →
19 2014 May
By FinSMEs
0 Comments

Coherus BioSciences Closes $55M Series C Financing

Coherus BioSciences, Inc., a San Francisco, CA-based biologics platform company focused on biosimilars, closed a $55m Series C financing. New...

Read More →
08 2014 January
By FinSMEs
0 Comments

Blueprint Medicines Completes $25M Series B Financing

Blueprint Medicines, a Cambridge, MA-based oncology company, completed a $25m Series B financing. The round was led by Nextech Invest...

Read More →
17 2013 December
By FinSMEs
0 Comments

ViewRay Secures $30M

ViewRay Incorporated, a Cleveland, Ohio-based medical device company, secured $30m in funding. Backers included existing equity investors Aisling Capital, Fidelity...

Read More →
26 2013 November
By FinSMEs
0 Comments

Pulmocide Raises £17M in Series A Funding

Pulmocide Ltd, a London, UK-based company that develops a new generation of inhaled medicines for the treatment of serious viral...

Read More →
04 2013 September
By FinSMEs
0 Comments

Acacia Pharma Raises £15M in Series B Financing

Acacia Pharma, a Cambridge, UK-based pharmaceutical company specializing in the development of drugs for supportive care, raised £15m (approximately $23.5m)...

Read More →
17 2013 April
By FinSMEs
0 Comments

Iora Health Raises $14M Series B Financing

Iora Health, a Cambridge MA-based private healthcare company, raised $14m in series B growth financing. Backers included original investors Fidelity Biosciences,...

Read More →
04 2013 March
By FinSMEs
1 Comments

US HealthVest Raises $36M in Funding

US HealthVest, a newly formed provider of specialized psychiatric care, raised $36m in funding. Backers included Polaris Partners, President and...

Read More →
02 2013 January
By FinSMEs
0 Comments

Kyruus Closes $11M Series B Financing

Kyruus, a Boston, MA-based healthcare Big Data company, has closed an $11m Series B financing. The round was led by...

Read More →
24 2012 October
By FinSMEs
0 Comments

Aclaris Therapeutics Secures $21M in Series A Financing

Aclaris Therapeutics, Inc., a Malvern, PA-based specialty pharmaceutical company dedicated to developing dermatological therapeutics, has secured $21m in Series A...

Read More →
31 2012 July
By FinSMEs
0 Comments

Mersana Therapeutics Raises $27M in Series A-1 Financing

Mersana Therapeutics Inc., a Cambridge, MA-based biopharmaceutical company, has raised $27m in Series A-1 financing. The round was led by...

Read More →
24 2012 May
By FinSMEs
0 Comments

Blueprint Medicines Adds Fidelity Biosciences

Blueprint Medicines, a Cambridge, MA-based developer of personalized cancer therapies, announced Fidelity Biosciences as a new investor. Fidelity Biosciences has...

Read More →
24 2012 April
By FinSMEs
0 Comments

Liazon Closes $18.2M in Funding

Liazon, an operator of a private health benefits exchange, has closed $18.2m in new funding . The round was led...

Read More →
13 2012 March
By FinSMEs
0 Comments

ViewRay Closes $45M Series C Venture Capital Financing

ViewRay Inc., a Cleveland, Ohio-based medical device company, has closed a $45m round of Series C venture capital financing. Backers...

Read More →